The hyper-activation of transcriptional enhancers in breast cancer.
Qing-Lan LiDan-Ya WangLin-Gao JuJie YaoChuan GaoPin-Ji LeiLian-Yun LiXiao-Lu ZhaoMin WuPublished in: Clinical epigenetics (2019)
Taken together, our work identifies novel regulators and provides important resource to the genome-wide enhancer studies in breast cancer and raises the possibility of cancer treatment through modulating enhancer activity.